Isomerase Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $155K

  • Investors
  • 2

Isomerase General Information

Description

Operator of a pharmaceutical drug company intended to support partners across all aspects of microbial product and process discovery and development. The company offers a comprehensive suite of services including drug discovery, with a strong focus on biotechnology, specialize in synthetic biology, microbial strain development, microbial genome editing, enzyme engineering, directed evolution, cell-free protein synthesis, enzyme manufacturing, fermentation optimization, and downstream process development with a capability extended to producing a wide range of products, from natural compounds and peptides to enzymes, agricultural goods, and consumer products by bridging advanced-stage concepts to valuable development program, providing the healthcare sector and patients with advanced-stage concepts into valuable development programs.

Contact Information

Website
www.isomerase.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Newnham Building, First Floor
  • Chesterford Research Park
  • Cambridge CB10 1XL
  • England, United Kingdom
+44 01223
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Newnham Building, First Floor
  • Chesterford Research Park
  • Cambridge CB10 1XL
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isomerase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Sep-2017 $155K Completed Generating Revenue
6. Grant 01-Feb-2017 Completed Generating Revenue
5. Early Stage VC 15-Aug-2016 Completed Generating Revenue
4. Grant 01-Jun-2016 Completed Startup
3. Grant 01-Apr-2015 Completed Startup
2. Angel (individual) 12-Nov-2014 $254K $254K Completed Startup
1. Grant 01-Nov-2014 $242K Completed Startup
To view Isomerase’s complete valuation and funding history, request access »

Isomerase Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Isomerase’s complete cap table history, request access »

Isomerase Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical drug company intended to support partners across all aspects of microbial product and proce
Other Pharmaceuticals and Biotechnology
Cambridge, United Kingdom
37 As of 2024

Emeryville, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Isomerase Competitors (2)

One of Isomerase’s 2 competitors is Amyris, a Private Equity-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris Private Equity-Backed Emeryville, CA
Ginkgo Bioworks Formerly VC-backed Boston, MA
You’re viewing 2 of 2 competitors. Get the full list »

Isomerase Patents

  • 36

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Isomerase Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202414984-D0 Novel methods Pending 11-Oct-2024
GB-202300816-D0 Novel method Inactive 19-Jan-2023
GB-202300632-D0 Novel methods Inactive 16-Jan-2023
GB-202200889-D0 Novel methods Inactive 24-Jan-2022
GB-202101009-D0 Novel methods Inactive 26-Jan-2021
To view Isomerase’s complete patent history, request access »

Isomerase Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Isomerase Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abliva Corporation Minority
Innovate UK Government
To view Isomerase’s complete investors history, request access »

Ready to get started?

Request a free trial

Isomerase FAQs

  • When was Isomerase founded?

    Isomerase was founded in 2012.

  • Where is Isomerase headquartered?

    Isomerase is headquartered in Cambridge, United Kingdom.

  • What is the size of Isomerase?

    Isomerase has 37 total employees.

  • What industry is Isomerase in?

    Isomerase’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Isomerase a private or public company?

    Isomerase is a Private company.

  • What is Isomerase’s current revenue?

    The current revenue for Isomerase is .

  • How much funding has Isomerase raised over time?

    Isomerase has raised $1.89M.

  • Who are Isomerase’s investors?

    Abliva and Innovate UK have invested in Isomerase.

  • Who are Isomerase’s competitors?

    Amyris and Ginkgo Bioworks are competitors of Isomerase.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »